CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate...
New York, New York, United States and 14 other locations
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
New York, New York, United States and 12 other locations
This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions invol...
Phase 2
New York, New York, United States and 9 other locations
drugs in a regimen called FOLFIRINOX, to patients who have pancreatic cancer which has metastasised (spread). The study is being ru...
Phase 1, Phase 2
New York, New York, United States and 5 other locations
study of PBP1510 administered to patients with advanced/metastatic pancreatic cancer. The study will be conducted in two parts, Par...
Phase 1, Phase 2
New Hyde Park, New York, United States and 3 other locations
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Bronx, New York, United States and 27 other locations
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
New York, New York, United States and 1 other location
The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed...
Phase 1
New York, New York, United States and 6 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
New York, New York, United States and 15 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
New York, New York, United States of America and 135 other locations
Clinical trials
Research sites
Resources
Legal